SCHEMBL21388922

SCHEMBL21388922

O=c1c2ccccc2c2cc(-n3c4ccccc4c4ccccc4c4ccccc4c4ccccc43)cc3c4ccccc4n1c23

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 1/20 0.46
KMT2A Q03164 3/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
POLB P06746 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
MAPK1 P28482 1/20 0.43
PTPN1 P18031 3/20 0.39
PGR P06401 2/20 0.37
RORA P35398 1/20 0.37
RORC P51449 1/20 0.37
RORB Q92753 1/20 0.37
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
CASP1 P29466 1/20 0.36
GALK1 P51570 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14732336 1.00 KDM4E (0.46) KDM4EL3MBTL1ATMKMT2AMAPT
SCHEMBL17107984 0.95 KDM4E (0.47) KDM4EL3MBTL1ATMKMT2AMAPT
SCHEMBL12181325 0.94 MAPT (0.41) KDM4EL3MBTL1ATMKMT2AMAPT
SCHEMBL12181304 0.88 TSPO (0.39) KDM4EL3MBTL1ATMKMT2AMAPT
SCHEMBL12181577 0.88 MAPT (0.48) KDM4EL3MBTL1ATMKMT2AMAPT
SCHEMBL25638804 0.88 KDM4E (0.54) KDM4EL3MBTL1ATMKMT2AMAPT
SCHEMBL22141210 0.86 KDM4E (0.43) KDM4EL3MBTL1ATMKMT2AMAPT
SCHEMBL17107986 0.86 L3MBTL1 (0.51) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL17108005 0.86 KDM4E (0.42) KDM4EL3MBTL1ATMKMT2AMAPT
SCHEMBL17146739 0.86 KDM4E (0.56) KDM4EL3MBTL1ATMKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3548481-B1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-08-23 EP disclosed
US-11329233-B2 Heterocyclic compounds for use in electronic devices MERCK PATENT GMBH (DE) 2022-05-10 US disclosed
US-20190296250-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190296250-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES NQO1, DDT, ETV6 KDM4E 1555/4885L3MBTL1 3899/4885ATM 4662/4885
US-11329233-B2 Heterocyclic compounds for use in electronic devices NQO1, DDT, ETV6 KDM4E 1555/4885L3MBTL1 3899/4885ATM 4662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.